These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 31882997)

  • 21. Compound 48/80 acts as a potent mucosal adjuvant for vaccination against Streptococcus pneumoniae infection in young mice.
    Zeng L; Liu Y; Wang H; Liao P; Song Z; Gao S; Wu Y; Zhang X; Yin Y; Xu W
    Vaccine; 2015 Feb; 33(8):1008-16. PubMed ID: 25595867
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intravaginal immunisation using a novel antigen-releasing ring device elicits robust vaccine antigen-specific systemic and mucosal humoral immune responses.
    McKay PF; Mann JF; Pattani A; Kett V; Aldon Y; King D; Malcolm RK; Shattock RJ
    J Control Release; 2017 Mar; 249():74-83. PubMed ID: 28115243
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Novel Supplementation Approach to Enhance Host Response to Sublingual Vaccination.
    Rowe JC; Attia Z; Kim E; Cormet-Boyaka E; Boyaka PN
    Sci Rep; 2019 Jan; 9(1):715. PubMed ID: 30679470
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Induction of mucosal immunity against herpes simplex virus by plasmid DNA immunization.
    Kuklin N; Daheshia M; Karem K; Manickan E; Rouse BT
    J Virol; 1997 Apr; 71(4):3138-45. PubMed ID: 9060677
    [TBL] [Abstract][Full Text] [Related]  

  • 25. IL-7-Adjuvanted Vaginal Vaccine Elicits Strong Mucosal Immune Responses in Non-Human Primates.
    Logerot S; Figueiredo-Morgado S; Charmeteau-de-Muylder B; Sandouk A; Drillet-Dangeard AS; Bomsel M; Bourgault-Villada I; Couëdel-Courteille A; Cheynier R; Rancez M
    Front Immunol; 2021; 12():614115. PubMed ID: 33717097
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mucosal immunization: a review of strategies and challenges.
    Patel H; Yewale C; Rathi MN; Misra A
    Crit Rev Ther Drug Carrier Syst; 2014; 31(4):273-303. PubMed ID: 25072196
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mucosal vaccines: a paradigm shift in the development of mucosal adjuvants and delivery vehicles.
    Srivastava A; Gowda DV; Madhunapantula SV; Shinde CG; Iyer M
    APMIS; 2015 Apr; 123(4):275-88. PubMed ID: 25630573
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Uniqueness of the mucosal immune system for the development of prospective mucosal vaccine].
    Kunisawa J; Gohda M; Kiyono H
    Yakugaku Zasshi; 2007 Feb; 127(2):319-26. PubMed ID: 17268152
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Development of oral vaccines].
    Matsubara A; Shimizu Y; Karamatsu K; Yasutomi Y
    Nihon Rinsho; 2008 Oct; 66(10):1873-8. PubMed ID: 18939484
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lactobacillus plantarum producing a Chlamydia trachomatis antigen induces a specific IgA response after mucosal booster immunization.
    Kuczkowska K; Myrbråten I; Øverland L; Eijsink VGH; Follmann F; Mathiesen G; Dietrich J
    PLoS One; 2017; 12(5):e0176401. PubMed ID: 28467432
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nanocarriers: a versatile approach for mucosal vaccine delivery.
    Mody N; Sharma R; Agrawal U; Vyas SP
    Ther Deliv; 2015 Feb; 6(2):231-45. PubMed ID: 25690089
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mucosal responses to parenteral and mucosal vaccines.
    Kaul D; Ogra PL
    Dev Biol Stand; 1998; 95():141-6. PubMed ID: 9855424
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Approaches to tuberculosis mucosal vaccine development using nanoparticles and microparticles: a review.
    Caetano LA; Almeida AJ; Gonćalves LM
    J Biomed Nanotechnol; 2014 Sep; 10(9):2295-316. PubMed ID: 25992458
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhanced mucosal immune responses induced by a combined candidate mucosal vaccine based on Hepatitis A virus and Hepatitis E virus structural proteins linked to tuftsin.
    Gao Y; Su Q; Yi Y; Jia Z; Wang H; Lu X; Qiu F; Bi S
    PLoS One; 2015; 10(4):e0123400. PubMed ID: 25875115
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New advances in mucosal vaccination.
    Ranasinghe C
    Immunol Lett; 2014 Oct; 161(2):204-6. PubMed ID: 24462961
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mucosal delivery of vaccines in domestic animals.
    Gerdts V; Mutwiri GK; Tikoo SK; Babiuk LA
    Vet Res; 2006; 37(3):487-510. PubMed ID: 16611560
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The mucosal immune system: From dentistry to vaccine development.
    Kiyono H; Azegami T
    Proc Jpn Acad Ser B Phys Biol Sci; 2015; 91(8):423-39. PubMed ID: 26460320
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Induction of systemic and mucosal immune response and decrease in Streptococcus pneumoniae colonization by nasal inoculation of mice with recombinant lactic acid bacteria expressing pneumococcal surface antigen A.
    Oliveira ML; Arêas AP; Campos IB; Monedero V; Perez-Martínez G; Miyaji EN; Leite LC; Aires KA; Lee Ho P
    Microbes Infect; 2006 Apr; 8(4):1016-24. PubMed ID: 16549380
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Roles of M cells in infection and mucosal vaccines.
    Wang M; Gao Z; Zhang Z; Pan L; Zhang Y
    Hum Vaccin Immunother; 2014; 10(12):3544-51. PubMed ID: 25483705
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mucosal and systemic responses of immunogenic vaccines candidates against enteric Escherichia coli infections in ruminants: A review.
    Lawan A; Jesse FFA; Idris UH; Odhah MN; Arsalan M; Muhammad NA; Bhutto KR; Peter ID; Abraham GA; Wahid AH; Mohd-Azmi ML; Zamri-Saad M
    Microb Pathog; 2018 Apr; 117():175-183. PubMed ID: 29471137
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.